These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 8001500

  • 1. MDR1 gene expression in brain of patients with medically intractable epilepsy.
    Tishler DM, Weinberg KI, Hinton DR, Barbaro N, Annett GM, Raffel C.
    Epilepsia; 1995 Jan; 36(1):1-6. PubMed ID: 8001500
    [Abstract] [Full Text] [Related]

  • 2. Tuberous sclerosis associated with MDR1 gene expression and drug-resistant epilepsy.
    Lazarowski A, Sevlever G, Taratuto A, Massaro M, Rabinowicz A.
    Pediatr Neurol; 1999 Oct; 21(4):731-4. PubMed ID: 10580886
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug resistance in epilepsy: expression of drug resistance proteins in common causes of refractory epilepsy.
    Sisodiya SM, Lin WR, Harding BN, Squier MV, Thom M.
    Brain; 2002 Jan; 125(Pt 1):22-31. PubMed ID: 11834590
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The drug-transporter gene MDR1 C3435T and G2677T/A polymorphisms and the risk of multidrug-resistant epilepsy in Turkish children.
    Seven M, Batar B, Unal S, Yesil G, Yuksel A, Guven M.
    Mol Biol Rep; 2014 Jan; 41(1):331-6. PubMed ID: 24213830
    [Abstract] [Full Text] [Related]

  • 8. Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy.
    Marroni M, Marchi N, Cucullo L, Abbott NJ, Signorelli K, Janigro D.
    Curr Drug Targets; 2003 May; 4(4):297-304. PubMed ID: 12699350
    [Abstract] [Full Text] [Related]

  • 9. Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption.
    Ponnala S, Chaudhari JR, Jaleel MA, Bhiladvala D, Kaipa PR, Das UN, Hasan Q.
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):550-7. PubMed ID: 22239287
    [Abstract] [Full Text] [Related]

  • 10. A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.
    Marchi N, Guiso G, Rizzi M, Pirker S, Novak K, Czech T, Baumgartner C, Janigro D, Caccia S, Vezzani A.
    Epilepsia; 2005 Oct; 46(10):1613-9. PubMed ID: 16190932
    [Abstract] [Full Text] [Related]

  • 11. Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.
    Soranzo N, Kelly L, Martinian L, Burley MW, Thom M, Sali A, Kroetz DL, Goldstein DB, Sisodiya SM.
    Epilepsia; 2007 Apr; 48(4):674-83. PubMed ID: 17437410
    [Abstract] [Full Text] [Related]

  • 12. Comparison of brain extracellular fluid, brain tissue, cerebrospinal fluid, and serum concentrations of antiepileptic drugs measured intraoperatively in patients with intractable epilepsy.
    Rambeck B, Jürgens UH, May TW, Pannek HW, Behne F, Ebner A, Gorji A, Straub H, Speckmann EJ, Pohlmann-Eden B, Löscher W.
    Epilepsia; 2006 Apr; 47(4):681-94. PubMed ID: 16650134
    [Abstract] [Full Text] [Related]

  • 13. In vivo evidence for P-glycoprotein-mediated transport of phenytoin at the blood-brain barrier of rats.
    Potschka H, Löscher W.
    Epilepsia; 2001 Oct; 42(10):1231-40. PubMed ID: 11737157
    [Abstract] [Full Text] [Related]

  • 14. The potential implication of MDR1 and NAC1 genetic polymorphisms on resistance to antiepileptic drugs among a Jordanian epileptic population: a cross-sectional study.
    Abduljabbar R, Tamimi DE, Yousef AM.
    Ann Hum Biol; 2023 Feb; 50(1):82-93. PubMed ID: 36714955
    [Abstract] [Full Text] [Related]

  • 15. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
    Lazarowski A, Czornyj L, Lubienieki F, Girardi E, Vazquez S, D'Giano C.
    Epilepsia; 2007 Feb; 48 Suppl 5():140-9. PubMed ID: 17910594
    [Abstract] [Full Text] [Related]

  • 16. Determining MDR1/P-glycoprotein expression in breast cancer.
    Faneyte IF, Kristel PM, van de Vijver MJ.
    Int J Cancer; 2001 Jul 01; 93(1):114-22. PubMed ID: 11391630
    [Abstract] [Full Text] [Related]

  • 17. Drug transporters in the epileptic brain.
    Löscher W.
    Epilepsia; 2007 Jul 01; 48 Suppl 1():8-13. PubMed ID: 17316407
    [Abstract] [Full Text] [Related]

  • 18. Reverse transcriptase-polymerase chain reaction amplification of MDR1 gene expression in adult soft tissue sarcomas.
    Oda Y, Schneider-Stock R, Ryś J, Gruchała A, Niezabitowski A, Roessner A.
    Diagn Mol Pathol; 1996 Jun 01; 5(2):98-106. PubMed ID: 8727096
    [Abstract] [Full Text] [Related]

  • 19. Limbic seizures induce P-glycoprotein in rodent brain: functional implications for pharmacoresistance.
    Rizzi M, Caccia S, Guiso G, Richichi C, Gorter JA, Aronica E, Aliprandi M, Bagnati R, Fanelli R, D'Incalci M, Samanin R, Vezzani A.
    J Neurosci; 2002 Jul 15; 22(14):5833-9. PubMed ID: 12122045
    [Abstract] [Full Text] [Related]

  • 20. Do ATP-binding cassette transporters cause pharmacoresistance in epilepsy? Problems and approaches in determining which antiepileptic drugs are affected.
    Löscher W, Luna-Tortós C, Römermann K, Fedrowitz M.
    Curr Pharm Des; 2011 Jul 15; 17(26):2808-28. PubMed ID: 21827408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.